Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Hookipa Pharma Inc. (HOOK)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 50,880,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   HOOKIPA Pharma is a biopharmaceutical company developing a class of immunotherapeutics based on its proprietary arenavirus platform that is designed to target and amplify a T cell and immune response to disease. Co. is building a proprietary immuno-oncology pipeline by targeting oncoviral cancer antigens, self-antigens and antigens. Co.'s lead replicating arenavirus oncology product candidates, HB-201 and HB-202, are in development for the treatment of Human Papillomavirus 16-positive cancers in a Phase 1/2 clinical trial. Co.'s non-replicating prophylactic Cytomegalovirus vaccine candidate, HB-101, is a potential compound in a Phase 2 clinical trial for kidney transplant patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 47,000 47,000
Total Buy Value $0 $0 $38,445 $38,445
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 7 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 59
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gilead Sciences Inc 10% Owner   –       –       •   2023-12-20 3 IO $0.00 $0 D/D 0 18,759,465     -
   Kandera Reinhard Chief Financial Officer   •       •      –    2023-08-21 4 B $0.73 $5,075 D/D 7,000 43,092 2.81     -
   Kandera Reinhard Chief Financial Officer   •       •      –    2023-08-16 4 B $0.71 $5,712 D/D 8,000 36,092 2.81     -
   Aldag Jorn Chief Executive Officer   •       •      –    2023-07-11 4 B $0.83 $4,142 D/D 5,000 71,952 2.73     -
   Aldag Jorn Chief Executive Officer   •       •      –    2023-07-07 4 B $0.81 $4,050 D/D 5,000 66,952 2.73     -
   Aldag Jorn Chief Executive Officer   •       •      –    2023-07-05 4 B $0.89 $4,450 D/D 5,000 61,952 2.73     -
   Aldag Jorn Chief Executive Officer   •       •      –    2023-07-03 4 B $0.89 $4,456 D/D 5,000 56,952 2.73     -
   Kandera Reinhard Chief Financial Officer   •       •      –    2023-06-30 4 B $0.88 $10,560 D/D 12,000 28,092 2.81     -
   Schlienger Katia Chief Medical OfficerOfficer   •       –      –    2023-03-09 3 IO $0.00 $0 I/I 0 1,300     -
   Baker Christine D. Chief Business Officer   •       –      –    2022-02-01 4 A $3.00 $40,974 D/D 13,658 16,158     -
   Orlinger Klaus Executive VP, Research   •       –      –    2022-02-01 4 A $3.00 $27,564 D/D 9,188 10,404     -
   Kandera Reinhard Chief Financial Officer   •       •      –    2022-02-01 4 A $3.00 $42,168 D/D 14,056 16,092     -
   Necina Roman Chief Technology Officer   •       –      –    2022-02-01 4 A $3.00 $38,676 D/D 12,892 14,876     -
   Matushansky Igor Chief Medical Officer   •       –      –    2022-02-01 4 A $3.00 $44,799 D/D 14,933 100,240     -
   Aldag Jorn Chief Executive Officer   •       •      –    2022-02-01 4 A $3.00 $143,472 D/D 47,824 51,952     -
   Matushansky Igor Chief Medical Officer   •       –      –    2021-12-21 4 S $2.49 $37,223 D/D (14,949) 85,307     -
   Matushansky Igor Chief Medical Officer   •       –      –    2021-12-21 4 OE $0.10 $2,285 D/D 22,853 87,512     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-04-21 4 S $11.60 $3,812,386 D/D (328,620) 3,177,574     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-29 4 AS $13.67 $503,570 D/D (36,829) 3,506,194     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-26 4 AS $13.69 $481,642 D/D (35,171) 3,543,023     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-25 4 AS $13.12 $374,569 D/D (28,546) 3,578,194     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-24 4 AS $13.70 $721,616 D/D (52,690) 3,606,740     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-23 4 AS $13.91 $556,476 D/D (40,000) 3,659,430     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-22 4 AS $14.54 $589,263 D/D (40,534) 3,699,430     -
   Sofinnova Partners Sas 10% Owner   –       –       •   2021-03-19 4 AS $14.60 $2,427,739 D/D (166,230) 3,739,964     -
  59 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us